Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

50.47
Delayed Data
As of 9:48am ET
 +0.35 / +0.70%
Today’s Change
13.20
Today|||52-Week Range
56.18
+125.92%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues0.000.000.0019.8M
 
 
Depreciation And Amortization208.0K217.0K224.0K244.0K
 
 
 
 
 
 
Operating ExpensesGross Income-208.0K-217.0K-224.0K--
 
 
 
 
General Expenses14.2M16.6M20.2M21.8M
 
 
 
 
 
Research And Development10.2M12.2M15.5M16.6M
 
 
 
 
 
Total Operating Expenses14.4M16.9M20.5M22.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.4M-16.9M-20.5M-2.3M
 
 
 
 
 
Other Expenses813.0K806.0K827.0K1.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-13.4M-15.9M-19.4M-1.2M
 
 
 
 
 
Net Income-13.4M-15.9M-19.4M-1.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS75.9M75.9M76.1M80.3M
 
 
 
 
 
Shares To Calculate EPS Diluted75.9M75.9M76.1M80.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.18-$0.21-$0.26-$0.01
 
 
 
 
 
EPS Diluted-$0.18-$0.21-$0.26-$0.01